3 months ago
RNA
AnalystsKeay NakaeKeay Nakae's Stock Forecasts
AnalystsKeay Nakae
Analyst Ranking
Top 5%
#253 out of 5014 analysts
Average Return
+14.35%
Win Rate
36%93 out of 255
Risk vs Reward
Poor
Good
Keay Nakae's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +5,554.71% | $0.22 | $12.61 | 2020-06-03 - 2021-02-09 | Strong Buy |
Sonnet Biotherapeutics Holdings IncSONN | +391.67% | $1.20 | $5.90 | 2025-04-07 - 2025-09-12 | Strong Buy |
Sonnet Biotherapeutics Holdings IncSONN | +350.38% | $1.31 | $5.90 | 2025-03-28 - 2025-09-12 | Strong Buy |
Avidity Biosciences IncRNA | +347.81% | $9.35 | $41.87 | 2023-08-09 - 2024-08-08 | Strong Buy |
Sonnet Biotherapeutics Holdings IncSONN | +278.21% | $1.56 | $5.90 | 2024-12-20 - 2025-09-12 | Strong Buy |
Keay Nakae Analyst Color
Get additional color on Keay Nakae's coverage of popular stocks
10 months ago
ABUS
10 months ago
ABUS
a year ago
RNA
a year ago
RNA
a year ago
SLN
a year ago
RNA
a year ago
DYN
a year ago
COYA
2 years ago
SLN
2 years ago
PRQR
2 years ago
DYN
2 years ago
RNA
2 years ago
COYA
2 years ago
SYBX
2 years ago
GANX
3 years ago
DYN
3 years ago
ALNY
3 years ago
BTTX
3 years ago
BTTX
4 years ago
ABUS
Keay Nakae's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avidity Biosciences IncRNA | 19 | Strong Buy | $75.00 | +67.64% | Maintains | 6 days ago |
Orchestra Biomed Holdings IncOBIO | 12 | Strong Buy | $20.00 | +678.21% | Maintains | a month ago |
Korro Bio IncKRRO | 3 | Strong Buy | $25.00 | -18.73% | Maintains | a month ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $60.00 | +21.90% | Maintains | a month ago |
Coya Therapeutics IncCOYA | 20 | Strong Buy | $14.00 | +131.40% | Maintains | a month ago |
Arrowhead Pharmaceuticals IncARWR | 16 | Strong Buy | $60.00 | +101.88% | Maintains | a month ago |
Arbutus Biopharma CorpABUS | 12 | Strong Buy | $5.00 | +12.11% | Maintains | a month ago |
Proqr Therapeutics NvPRQR | 12 | Strong Buy | $4.00 | +82.65% | Maintains | a month ago |
Sab Biotherapeutics IncSABS | 15 | Strong Buy | $12.00 | +466.04% | Maintains | a month ago |
Silence Therapeutics PLCSLN | 13 | Strong Buy | $35.00 | +676.05% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 12 | Strong Buy | $400.00 | -14.14% | Maintains | a month ago |
Dyne Therapeutics IncDYN | 13 | Strong Buy | $38.00 | +188.97% | Maintains | 2 months ago |
Ibio IncIBIO | 5 | Strong Buy | $5.00 | +435.91% | Maintains | 3 months ago |
Seres Therapeutics IncMCRB | 10 | Hold | $6.00 | -62.29% | Downgrades | 4 months ago |
Sonnet Biotherapeutics Holdings IncSONN | 13 | Strong Buy | $20.00 | +238.98% | Maintains | 5 months ago |
Gain Therapeutics IncGANX | 6 | Strong Buy | $6.00 | +261.45% | Maintains | 6 months ago |
Allurion Technologies IncALUR | 5 | Hold | $2.50 | +15.74% | Maintains | 6 months ago |
Femasys IncFEMY | 10 | Strong Buy | $8.00 | +1,940.82% | Maintains | 10 months ago |
Omega Therapeutics IncOMGAQ | 6 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Notable Labs LtdNTBLQ | 2 | Strong Buy | $5.00 | N/A | Maintains | a year ago |
Synlogic IncSYBX | 4 | Strong Buy | $90.00 | N/A | Reiterates | 2 years ago |
Better Therapeutics IncBTTX | 6 | Strong Buy | $9.00 | N/A | Reiterates | 2 years ago |
Mesoblast LtdMESO | 7 | Strong Sell | $6.00 | N/A | Maintains | 2 years ago |
Pear Therapeutics IncPEARQ | 5 | Hold | $8.00 | N/A | Downgrades | 2 years ago |
Evelo Biosciences IncEVLO | 4 | Hold | $50.00 | N/A | Downgrades | 3 years ago |
Biomx IncPHGE | 4 | Strong Buy | $20.00 | N/A | Maintains | 3 years ago |
Emergent Biosolutions IncEBS | 8 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Axcella Health IncAXLA | 4 | Strong Buy | $125.00 | N/A | Maintains | 3 years ago |
Neubase Therapeutics IncNBSE | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Exicure IncXCUR | 5 | Hold | $10.00 | N/A | Maintains | 3 years ago |
4d Pharma PLCLBPS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Kaleido Biosciences IncKLDO | 3 | Hold | $1.70 | N/A | Downgrades | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 3 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Forte Biosciences IncFBRX | 2 | Hold | $87.50 | N/A | Upgrades | 4 years ago |
Ocugen IncOCGN | 2 | Hold | $13.00 | N/A | Downgrades | 5 years ago |
Insight Molecular Diagnostics IncIMDX | 2 | Hold | $40.00 | N/A | Downgrades | 5 years ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $7.00 | N/A | Maintains | 7 years ago |
Carecloud IncCCLD | 1 | Strong Buy | $2.75 | N/A | Maintains | 8 years ago |
Biocept IncBIOCQ | 1 | Strong Buy | $22,500.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.